The first Eagle Pharmaceuticals trade was made in Q1 2023. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Eagle Pharmaceuticals anymore.
WOODCLIFF LAKE, N.J., June 09, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced it has complete...
Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) has agreed to acquire Acacia Pharma Group plc for approximately €94.7 million , equivalent to €0.90 per share. Each...
Eagle Pharmaceuticals (EGRX) is acquiring U.K.-based Acacia Pharma Group (ACPGF) The terms of the proposed transaction value Acacia’s existing issued and to ...
Susquehanna International Group LLP lifted its stake in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) by 57.0% during the second quarter, according to ...